THERANOSTICS 2016* Ashwani Sood
PGIMER, PUNJAB, India
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Safety and efficacy of peptide receptor radionuclide therapy (PRRT) using Lu-177 DOTATATE and capecitabine as a radiosensitizer in metastatic neuroendocrine tumors (NETs) (#60)
8:30 AM
Ashwani Sood
Conference Breakfast: Moderated Poster Walk - Neuroendocrine tumours
Role of Ga-68 DOTANOC PET/CT scan in chemotherapy response evaluation in patients with neuroblastoma (#55)
8:30 AM
Deepa Singh
Conference Breakfast: Moderated Poster Walk - Neuroendocrine tumours
Lutetium-177 (Lu-177) labeled EDTMP for metastatic bone pain palliation- initial experience at a tertiary care centre in India (#83)
8:30 AM
Deepa Singh
Conference Breakfast: Moderated Poster Walk - Prostate tumours